Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02573142 · ClinicalTrials.gov registry record · NA

Integrated Child Obesity Treatment Study: Bull City Healthy and Fit

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
97
Enrollment target

NCT02573142: Completed NA study, sponsored by Duke University.

NCT02573142 is a NA study that has completed, run by Duke University. The registered enrollment target is 97 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02573142, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
97 participants
Enrollment target

Study Summary

The primary aim of this study is to reduce body mass index (BMI) among children ages 5-11 who are obese by integrating behavioral treatment strategies in both clinic (Healthy Lifestyles) and community (Bull City Fit) settings. A two-group randomized, controlled, non-blinded pilot design will be utilized. The intended target population is the adult caregiver and a child with obesity (BMI ≥ 95th percentile) aged 5-11. The intervention condition will be standard care with Healthy Lifestyles programming plus Bull City Fit; upcoming activities will be texted to the parents mobile device using GoogleVoice. The control condition will be standard clinical care with Healthy Lifestyles programming. Primary outcome is BMI at 6 months. Secondary outcomes include anthropometric, psychosocial, and reported health behaviors.

Primary Outcome

Body mass index will be measured at 3- and 6-months post-enrollment.

Interventions

  • BEHAVIORAL Bull City Healthy and Fit
  • BEHAVIORAL Healthy Lifestyles Clinic

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2015-10
Est. Completion 2017-03-13
Phase NA
Duke University

1,725 total trials

What the finished NCT02573142 record still lists

NCT02573142 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Bull City Healthy and Fit is the first listed.

NCT02573142 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02573142 about?

NCT02573142 is a clinical study titled "Integrated Child Obesity Treatment Study: Bull City Healthy and Fit". The primary aim of this study is to reduce body mass index (BMI) among children ages 5-11 who are obese by integrating behavioral treatment strategies in both clinic (Healthy Lifestyles) and community (Bull City Fit) settings. A two-group randomized, controlled, non-blinded pilot design will be util...

What is the current status of trial NCT02573142?

This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2015-10. Estimated completion is 2017-03-13.

What interventions are being tested in trial NCT02573142?

The interventions under investigation include: Bull City Healthy and Fit (BEHAVIORAL), Healthy Lifestyles Clinic (BEHAVIORAL).

Who is sponsoring clinical trial NCT02573142?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02573142's enrollment target sits among peer trials

97 923rd of 2000 higher than 1,076 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03948490 · 97 participants · NA

    Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas

  • NCT04140487 · 97 participants · Phase 1

    Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

  • NCT04196413 · 97 participants · Phase 1

    GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

  • NCT05223816 · 97 participants · Phase 2

    An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02573142, the US trial registry maintained by the National Library of Medicine. NCT02573142 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.